HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the ...

Regenerative Medicine Market OverviewThe regenerative medicine market is projected to grow at a robust CAGR of 17% during the forecast period, driven by rising chronic disease incidence, increasing ...

Whenever I discuss stem cell therapies with non-biologist friends, I’m struck by how confused they often are about what stem cells actually are and what they do. There is particular confusion in ...

The financing will, in part, support an upcoming Phase IIIb trial of its beleaguered stem cell therapy for amyotrophic lateral sclerosis.

Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies are working hard to make advancements that can help patients. Stem cells ...